Imatinib Interactions
There are 763 drugs known to interact with imatinib, along with 7 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 136 are major, 601 are moderate, and 26 are minor.
- View all 763 medications that may interact with imatinib
- View imatinib alcohol/food interactions (1)
- View imatinib disease interactions (7)
Most frequently checked interactions
View interaction reports for imatinib and the medicines listed below.
- Aspirin Low Strength (aspirin)
- Aspirin Low Strength (aspirin)
- Benadryl (diphenhydramine)
- Benadryl (diphenhydramine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Eliquis (apixaban)
- Eliquis (apixaban)
- Jardiance (empagliflozin)
- Jardiance (empagliflozin)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Synthroid (levothyroxine)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
- Zyrtec (cetirizine)
- Zyrtec (cetirizine)
Imatinib alcohol/food interactions
There is 1 alcohol/food interaction with imatinib.
Imatinib disease interactions
There are 7 disease interactions with imatinib which include:
- cardiovascular disease
- fluid retention
- bone marrow suppression
- gastrointestinal disorders
- hepatic impairment
- hypothyroidism
- renal impairment
Report options
More about imatinib
- imatinib consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (47)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Bosulif
Bosulif is a kinase inhibitor that may be used to treat adults and some children aged 1 year and ...
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
